drugset / Trial / NCT05934253

The Effects of Low Viscosity Chloroprocaine Ophthalmic Gel 3% on the Bactericidal Action of Povidone-Iodine

NCT05934253

Phase 4 Completed 100 enrolled Harrow Inc
RandomizedCrossoverDouble-blindPrevention

Summary

To evaluate if Iheezo's (chloroprocaine 3%) gel vehicle acts as a barrier on the ocular surface, potentially blocking the bactericidal action of povidone-iodine.

Timeline

Start
2023-07-15
Primary completion
2024-01-15
Completion
2024-02-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Chloroprocaine Other / unclassified 3 % Topical

Indications

No indication recorded.